← FDA DRUG APPROVALS

FDA ANDA · ANDA086147

AMITRIPTYLINE HYDROCHLORIDE

Sponsor: ROXANE

APPLICATION
ANDA086147
TYPE
ANDA
ORIGINAL APPROVAL
1978-01-23
LATEST ACTION
1984-01-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

AMITRIPTYLINE HYDROCHLORIDEDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 75MG · TABLET · ORAL

Approval history

1984-01-13Manufacturing (CMC) · Supplement 12AP
1978-01-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →